185495 Pharmaceutical Countermeasures

Saturday, October 25, 2008: 10:45 AM

Jeffrey B. Nemhauser, MD , CDR, US Public Health Service, Medical Officer, CDC/Radiation Studies Branch, Atlanta, GA
Guidelines for assisting public health officials in determining whether pharmaceutical countermeasures should be deployed by the CDC strategic national stockpile will be discussed. The uses and limitations of the four major drugs in the strategic national stockpile that might be deployed following a radiation emergency will be discussed

Learning Objectives:
6. Discuss key considerations in public health planning for distribution of pharmaceutical countermeasures following a radiological terrorism incident.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a physician double-boarded in emergency medicine and toxicology. I am a commander in the U.S. Public Health Service. For the past three years I have worked exclusively in the field of radiation health protection and radiological/nuclear emergency preparedness at the Centers for Disease Control and Prevention. I have lectured extensively on the topic of radiological/nuclear emergencies. I am managing assistant editor of the online educational program 'Radiation Event Medical Management' produced by the U.S. Department of Health and Human Services.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

See more of: Public Health Planning for Response to Radiological and Nuclear Terrorism Incidents
See more of: APHA-Learning Institute (APHA-LI)